Demandas judiciais por medicamentos antineoplásicos: a ponta de um iceberg?

Vidal, Thaís Jeronimo; Moraes, Elaine Lazzaroni; Retto, Maely Peçanha Favero; Silva, Mario Jorge Sobreira da.
Ciênc. Saúde Colet. (Impr.) ; 22(8): 2539-2548, Ago. 2017. tab, graf
Artigo em Português | LILACS | ID: biblio-890413

Documentos relacionados

  1. The lawsuits to antineoplastic drugs: the tip of an iceberg?
  2. [Dispensing of oral anticancer drugs by retail pharmacies: professional requirements and recommendations].
  3. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
  4. A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience.
  5. Drug supply issues affecting cancer care in Latin America.
  6. Shortages of essential cancer medicines: who is responsible and what are the possible solutions?
  7. Oncology drugs in the crosshairs of pharmaceutical crime.
  8. WHO and St Jude Children's Research Hospital announce childhood cancer medicines initiative.
  9. Sanctions: Interim initiative for health in Iran.
  10. Lack of medicines in Mexico.